Our study revealed that PINX1 maintains cellular DNA damage repair capacity independently of telomerase inhibition, introducing a new facet to PINX1’s function as a partner of PARP1, whose deletion sensitizes tumor cells to PARPi. This evidence concerns the gene PARP1 and neoplasm.